Tsuyoshi Yorimitsu
Papers
1
Total Citations
14
H-Index
1
About
Tsuyoshi Yorimitsu is a pioneering researcher at the intersection of regenerative medicine and robotics, specializing in the automation of cell therapy manufacturing. His primary research areas include robotic cell processing, clinical-grade cell culture automation, and the development of Good Manufacturing Practice (GMP)-compliant facilities for retinal cell therapy. Yorimitsu’s major contribution is the design and validation of a robotic cell-processing facility (R-CPF) that employs humanoid robots to consistently produce high-quality therapeutic cells, directly addressing the scalability and reproducibility challenges in cell therapy. His most-cited work, a 2023 study on the R-CPF for retinal cell therapy, has garnered 14 citations and demonstrates a paradigm shift from manual to automated clinical production. This achievement not only reduces human error but also facilitates technology transfer for widespread adoption. By integrating robotics into sensitive biological processes, Yorimitsu has laid the groundwork for cost-effective, large-scale manufacturing of cell-based treatments, bringing personalized regenerative therapies closer to routine clinical reality.
Research Focus
Key Achievements
Top Papers
- 1